SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001583648-18-000038
Filing Date
2018-06-14
Accepted
2018-06-14 16:44:49
Documents
5
Period of Report
2018-06-14
Effectiveness Date
2018-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A pieris-2018proxystatement.htm DEF 14A 639457
2 a180523pieris2018prox_image1.jpg GRAPHIC 19022
3 a180523pieris2018prox_image2.gif GRAPHIC 2673
4 p1.jpg GRAPHIC 220450
5 p2.jpg GRAPHIC 244615
  Complete submission text file 0001583648-18-000038.txt   1285777
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37471 | Film No.: 18899677
SIC: 8731 Services-Commercial Physical & Biological Research